article thumbnail

Gilead CEO Daniel O'Day collects 5% pay raise to $22.6M, his largest compensation package in years

Fierce Pharma

After a year marked by Gilead's oncology push and an ongoing focus on CAR-T therapies, CEO Daniel O’Day collected his largest total compensation package since the year he arrived at the Califo | The CEO collected his highest total compensation package since his first year in the role in 2019.

article thumbnail

Sustainable pharma packaging: breaking down the barriers to adoption

European Pharmaceutical Review

For most consumers, product packaging represents their first impression of a brand and its sustainability credentials. But how is this push shaping the pharma packaging market and what are the key changes we can expect to see? For many, aesthetic appeal and user experience top the list of priorities when it comes to packaging design.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Kellogg’s is going to war over Mexico’s nutrition label rules. A similar fight is coming to the U.S.

STAT

A 2019 policy requires companies that make unhealthy foods to include warning labels on the front of any boxes they sell in Mexico to educate consumers about things like excess sugar and fat. MEXICO CITY — Kellogg’s is waging a war here over Tigre Toño and Sam el Tucán. Read the rest…

article thumbnail

STAT+: Not-for-profit CommonSpirit Health paid its CEO $35 million in 2021

STAT

CommonSpirit Health, the massive not-for-profit health system formed through a 2019 merger, paid its former CEO $35.5   The size of Lloyd Dean’s pay package is likely to reignite questions about health system CEO pay, especially at tax-exempt organizations. million in 2021, the latest year for which data is available. 

article thumbnail

STAT+: Pharmalittle: Italy probes Pfizer over profit transfers; FDA postpones meeting for OTC birth control pill

STAT

This calls for celebration with a cup of stimulation, and we are opening a new package of Pumpkin Spice for the occasion. The investigation began in February and covers 2017, 2018, and 2019. Autumn, after all, is in full swing. Meanwhile, our ever-growing to-do list requires attention. Sound familiar?

article thumbnail

Proposed non-animal derived reagent Chapter published

European Pharmaceutical Review

2019], the USP Microbiology Expert Committee proposed the inclusion of recombinant factors for endotoxin testing in chapter <85> Bacterial Endotoxins Test. This revision proposal will include methods for recombinant Factor C (rFC) and recombinant cascade reagents (rCR). In a recent publication in the Pharmacopeial Forum 45(5) [Sep.-Oct.

article thumbnail

Why demand is rising for secure and climate-controlled gene therapy services

Pharmaceutical Technology

It is critical to understand the supply chain, plan your packaging, storage and distribution lanes, then test the entire process before patient shipments go live. Products are stored and packaged in a dedicated suite by a dedicated team,” explains MacNeir. The requirements When handling personalised medicines, time is of the essence.